SpaceX Stock Closed First Day: Buy or Wait for Hype to Cool?
SpaceX just joined the public markets with a thunderous first day. A 19% gain sparked headlines, but smart investors ...
Ways To Save Money While Studying
Learn various ways to save money while studying, helping you build your financial skills and enjoy a more manageable budget during college.
27,538 articles
Trump Warns Israel Iran as Ceasefire Pact Hangs in Balance
Markets trembled as weekend violence surged near a looming ceasefire pact. Trump warned Israel Iran to keep the accor...
Gilgo Beach Serial Killer Reading Crime Novels in Jail
A high-profile inmate known as the Gilgo Beach serial killer is spending years in isolation, reading crime fiction, a...
Palantir Rises as Cloudflare Pops on AI Security Bets
Palantir rises about 5% and Cloudflare climbs roughly 3% as investors pile into AI security plays during a broad risk...
Here Tuesday’s Best Wall Street Calls Signal Mixed Rally
U.S. stocks and futures react to a fresh batch of analyst calls on Dynatrace, Emerson Electric, Exxon Mobil and more....
Mark Zuckerberg’s Ringside Seat Roils Anthropic Stock
Meta is pulling ahead in the AI talent race as policy headwinds tighten, placing Anthropic on the defensive and rattl...
These 84-Ft L.A. Towers Signal Housing Market Shakeup
A pair of 84-foot-tall towers moving through Los Angeles approvals could redefine housing reform in the city. The Riv...
Does SCHD Deserve Core Dividend Slot in a $500K Portfolio?
A retiree faces a pivotal choice between VIG and SCHD to anchor a $500,000 dividend strategy. The decision hinges on ...
Bill Ackman Reveals Key SpaceX Cornerstone for Value
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...
U.S. Government-Backed Materials Stock: Is It Time to Buy?
A major U.S. player in rare-earth magnets has fallen from its peak as policy shifts promise supply-chain resilience. ...
Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
AppLovin Could $600+ with AI Ad-Tech Rebound: Stock Outlook
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status